Progress of New Technologies in Gastric Cancer Minimally Invasive Treatments

Nowadays, gastric cancer treatment presents both exciting opportunities and persistent challenges. The development of new technologies in gastric cancer minimally invasive treatments has greatly improved clinical outcomes. Functional laparoscopy has enabled significant success in clinical treatments, while innovations in 3D laparoscopy, 3D combined fluorescent laparoscopy, da Vinci robotic, and other surgical techniques have introduced transformative changes. However, precise tumor positioning under laparoscopy is relatively difficult due to the lack of tactile feedback and direct observation compared with open surgery. Dye-mediated surgical navigation has therefore been developed and applied, which has been shown to provide surgeons with improved inspection of the complex perigastric anatomy during laparoscopic surgery. Particularly, Indocyanine Green (ICG), notable for its high tissue penetration and minimal interference with the surgical field, is increasingly used in laparoscopic and Da Vinci robotic radical gastrectomy. In addition, various researchers have achieved different outcomes regarding the treatment of the gastroesophageal junction, providing evidence for the application of new technologies. However, the exploration and application of new technologies for gastric cancer still require further research to be substantiated.

In this Research Topic, we hope to gather research evidence on new technologies in gastric cancer and accelerate the advancement in gastric cancer minimally invasive treatment. For example, we would like to further investigate the impact of indocyanine green and other labeling methods on radical gastrectomy in gastric cancer. We seek to elucidate the mechanism of Indocyanine Green fluorescence-guided laparoscopic and Da Vinci robotic radical gastrectomy and provide both theoretical and clinical basis for future gastric cancer labeling techniques. Additionally, we will explore advanced functional laparoscopy technologies, such as 3D, 4K, and fluorescence laparoscopy, to develop more effective clinical strategies for the minimally invasive and precise treatment of gastric cancer.

Specifically, manuscripts including, but not limited to the following sub-topics are highly welcome:
● Application of Indocyanine Green and other labeling methods in 3D laparoscopy, 3D combined fluorescent laparoscopy, da Vinci robotic, and other surgical techniques.
● Selection of 3D laparoscopy, 3D combined fluorescent laparoscopy, da Vinci robotic and other surgical techniques.
● Range effects of 3D laparoscopy, 3D combined fluorescent laparoscopy, da Vinci robotic, and other surgical techniques in radical gastrectomy.
● Safety and necessity of new technologies for radical gastrectomy.

Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.

Keywords: Gastric Cancer, Laparoscopic Surgery, Indocyanine Green, Da Vinci Robotic Surgery

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.